Showing results (181-190 of 3,692) with videos related to
Sort By:
Pageof 370
International Journal of Clinical Oncology|June 2, 2010
Diagnosis of primary versus metastatic ovarian adenocarcinoma using p53 gene mutation analysisTomoki Yamano, Eiichi Morii, Isao Arai, et al.International Journal of Clinical Oncology|May 14, 2010
Amrubicin for treating elderly and poor-risk patients with small-cell lung cancerSatoshi Igawa, Shinichiro Ryuge, Tomoya Fukui, et al.International Journal of Clinical Oncology|March 31, 2010
Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patientTakahiro Maeda, Eiji Kikuchi, Kazuhiro Matsumoto, et al.International Journal of Clinical Oncology|April 1, 2010
Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settingsYan Chen, Mingang Ying, YanSong Chen, et al.International Journal of Clinical Oncology|August 26, 2009
Bilateral adrenal leiomyosarcoma treated with multiple local therapiesShinsuke Hamada, Keiichi Ito, Musashi Tobe, et al.International Journal of Clinical Oncology|August 26, 2009
Nonbacterial thrombotic endocarditis complicated with stage Ia ovarian cancerHirohiko Tanaka, Masako Ito, Kayo Yoshida, et al.International Journal of Clinical Oncology|March 25, 2011
High estrogen receptor expression and low Ki67 expression are associated with improved time to progression during first-line endocrine therapy with aromatase inhibitors in breast cancerYumi Endo, Tatsuya Toyama, Satoru Takahashi, et al.International Journal of Clinical Oncology|April 21, 2015
Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography eraTakeshi Yuasa, Naoko Inoshita, Hajime Tanaka, et al.International Journal of Clinical Oncology|May 13, 2020
Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutesKazuyuki Numakura, Mizuki Kobayashi, Shingo Hatakeyama, et al.International Journal of Clinical Oncology|May 13, 2020
Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapyTakeshi Yamada, Akihisa Matsuda, Goro Takahashi, et al.Pageof 370